NORTH HAVEN, Conn.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback